Updates on Aflibercept BPCIA Litigation - February 2024 | Go

On Friday, January 20, 2024, Regeneron Pharmaceuticals, Inc. (“Regeneron”) filed an ex parte application for a scheduling order setting the schedule for preliminary injunction...

Related Keywords

West Virginia , United States , California , , Celltrion Inc , Amgen , Judicial Panel On Multidistrict Litigation , Us District Court , Biocon Biologics Inc , Regeneron Pharmaceuticals Inc , Mylan Pharmaceuticals Inc , Amgen Inc , Samsung Bioepis Co , Regeneron Pharmaceuticals , Judicial Panel , Northern District , Central District , Chief Judge Kleeh , Multidistrict Litigation , Seein Re Aflibercept Patent Litig , Mylan Pharmaceuticals , Big Molecule Watch ,